ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
21.98
+0.64 (3.00%)
Jun 6, 2025, 12:50 PM - Market open

ACADIA Pharmaceuticals Statistics

Total Valuation

ACAD has a market cap or net worth of $3.68 billion. The enterprise value is $3.05 billion.

Market Cap 3.68B
Enterprise Value 3.05B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date Aug 5, 2025
Ex-Dividend Date n/a

Share Statistics

ACAD has 167.36 million shares outstanding. The number of shares has increased by 1.32% in one year.

Current Share Class 167.36M
Shares Outstanding 167.36M
Shares Change (YoY) +1.32%
Shares Change (QoQ) +0.58%
Owned by Insiders (%) 0.56%
Owned by Institutions (%) 73.44%
Float 114.81M

Valuation Ratios

The trailing PE ratio is 16.05 and the forward PE ratio is 46.35. ACAD's PEG ratio is 3.52.

PE Ratio 16.05
Forward PE 46.35
PS Ratio 3.56
Forward PS 4.44
PB Ratio 4.66
P/TBV Ratio 5.67
P/FCF Ratio 24.75
P/OCF Ratio 24.66
PEG Ratio 3.52
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.98, with an EV/FCF ratio of 20.53.

EV / Earnings 13.32
EV / Sales 3.06
EV / EBITDA 29.98
EV / EBIT 34.50
EV / FCF 20.53

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.07.

Current Ratio 2.88
Quick Ratio 2.63
Debt / Equity 0.07
Debt / EBITDA 0.50
Debt / FCF 0.38
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 37.24% and return on invested capital (ROIC) is 8.21%.

Return on Equity (ROE) 37.24%
Return on Assets (ROA) 5.56%
Return on Invested Capital (ROIC) 8.21%
Return on Capital Employed (ROCE) 10.65%
Revenue Per Employee $1.52M
Profits Per Employee $349,974
Employee Count 654
Asset Turnover 1.00
Inventory Turnover 9.45

Taxes

In the past 12 months, ACAD has paid $35.97 million in taxes.

Income Tax 35.97M
Effective Tax Rate 13.58%

Stock Price Statistics

The stock price has increased by +43.28% in the last 52 weeks. The beta is 0.65, so ACAD's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change +43.28%
50-Day Moving Average 17.38
200-Day Moving Average 17.03
Relative Strength Index (RSI) 66.71
Average Volume (20 Days) 2,714,136

Short Selling Information

The latest short interest is 15.24 million, so 9.11% of the outstanding shares have been sold short.

Short Interest 15.24M
Short Previous Month 15.26M
Short % of Shares Out 9.11%
Short % of Float 13.28%
Short Ratio (days to cover) 8.49

Income Statement

In the last 12 months, ACAD had revenue of $996.28 million and earned $228.88 million in profits. Earnings per share was $1.37.

Revenue 996.28M
Gross Profit 595.17M
Operating Income 88.36M
Pretax Income 45.74M
Net Income 228.88M
EBITDA 101.67M
EBIT 88.36M
Earnings Per Share (EPS) $1.37
Full Income Statement

Balance Sheet

The company has $681.58 million in cash and $56.01 million in debt, giving a net cash position of $625.57 million or $3.74 per share.

Cash & Cash Equivalents 681.58M
Total Debt 56.01M
Net Cash 625.57M
Net Cash Per Share $3.74
Equity (Book Value) 765.24M
Book Value Per Share 4.58
Working Capital 568.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $148.96 million and capital expenditures -$523,000, giving a free cash flow of $148.44 million.

Operating Cash Flow 148.96M
Capital Expenditures -523,000
Free Cash Flow 148.44M
FCF Per Share $0.89
Full Cash Flow Statement

Margins

Gross margin is 59.74%, with operating and profit margins of 8.87% and 22.97%.

Gross Margin 59.74%
Operating Margin 8.87%
Pretax Margin 26.58%
Profit Margin 22.97%
EBITDA Margin 10.20%
EBIT Margin 8.87%
FCF Margin 14.90%

Dividends & Yields

ACAD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.32%
Shareholder Yield -1.32%
Earnings Yield 6.23%
FCF Yield 4.04%

Analyst Forecast

The average price target for ACAD is $27.00, which is 22.84% higher than the current price. The consensus rating is "Buy".

Price Target $27.00
Price Target Difference 22.84%
Analyst Consensus Buy
Analyst Count 16
Revenue Growth Forecast (5Y) 11.26%
EPS Growth Forecast (5Y) 16.53%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ACAD has an Altman Z-Score of 3.58 and a Piotroski F-Score of 5.

Altman Z-Score 3.58
Piotroski F-Score 5